B

BioMarin

Orphan-drug biotech focused on rare diseases

Senior Medical Director - Clinical Science

Biology & BiotechPosted on Nov 17
Full-timeLondon, UKNo salary listedIn-person

About the Job

Requirements

  • An MD or MD/PhD, or international equivalent, is required.
  • Typically, 10 or more years of experience in biotechnology, pharmaceutical development, academic medicine, or related fields is required.
  • Significant experience leading clinical programs across multiple phases, including registrational studies, is required.
  • Demonstrated experience interacting with global regulatory authorities and contributing to major submissions is required.
  • Experience in rare genetic, metabolic, or orphan disease development is strongly preferred.
  • Prior experience as a Medical Monitor and leading cross-functional development teams is required.
  • Strong scientific writing, executive communication, and stakeholder influence skills are required.

Responsibilities

  • Own clinical development strategy for one or more assets and develop Clinical Development Plans aligned with product strategy and corporate objectives.
  • Serve as clinical development team leader for assigned programs through registration and lifecycle management.
  • Drive clinical strategy discussions with senior management and participate in Program Review Committee and Development Governance, making recommendations at key decision points based on safety, efficacy, and benefit-risk considerations.
  • Identify opportunities to accelerate timelines, optimize study designs, and mitigate program risks in alignment with the scientific, medical, regulatory, and commercial landscape.
  • Lead regulatory strategy development with Regulatory Affairs and represent Clinical Science in interactions with global health authorities, including FDA, EMA, and PMDA.
  • Lead preparation for and participation in regulatory milestone meetings, including End-of-Phase 2, Breakthrough Therapy, Accelerated Approval pathway discussions, and BLA/NDA/MAA preparation.
  • Lead authoring and review of regulatory documents, including Clinical Development Plans, Investigator Brochures, Briefing Books, Pediatric Investigation Plans, IND Annual Reports, Clinical Study Reports, Integrated Summaries, and marketing application submissions.
  • Provide strategic scientific input into responses to regulatory questions and commitments, and support inspection readiness and Good Clinical Practice compliance.
  • Lead the scientific rationale for protocols, endpoints, and statistical approaches, partnering with Biometrics on analysis plans supporting regulatory objectives.
  • Provide strategic oversight of clinical study execution and guide study teams in resolving complex scientific, operational, and medical challenges.
  • Serve as Medical Monitor on selected studies, as appropriate.
  • Lead interactions with Data Monitoring Committees, Safety Review Committees, and external expert panels.
  • Lead review and interpretation of efficacy, safety, biomarker, and exploratory data to inform program decisions, and run data review meetings with scientific recommendations for development teams and senior leadership.
  • Oversee safety signal evaluation and partner with Pharmacovigilance on risk assessment and benefit-risk evaluation.
  • Present clinical findings and strategic recommendations to executive leadership and governance committees.
  • Maintain expertise in disease biology, treatment landscape, and emerging science, serving as the clinical and scientific leader for the assigned therapeutic area.
  • Build and sustain relationships with global thought leaders, investigators, professional societies, and patient advocacy organizations.
  • Drive publication strategy, scientific communications, advisory boards, and congress activities supporting development programs.
  • Provide dematrixed mentorship to Clinical Scientists, Associate Medical Directors, and Medical Directors.
  • Contribute to Clinical Science capability planning, recruitment, training, and retention strategies.
  • Contribute to departmental process improvement and the evolution of standard operating procedures, decision frameworks, and best practices.
  • Foster a culture of scientific excellence, accountability, collaboration, and patient focus.
  • Serve as a clinical expert supporting new project identification, including internal pipeline opportunities and external business development assessments.

Desired Qualifications

  • Board certification or specialty training is preferred.
  • Experience with gene therapy or enzyme replacement therapy is a plus.

About the Company

BioMarin

Orphan-drug biotech focused on rare diseases

BioMarin Pharmaceutical focuses on developing and selling medicines for people with rare genetic diseases. It creates orphan drugs—therapies designed for small patient populations—and has a lineup of approved treatments such as Vimizim (enzyme replacement for Morquio A syndrome), Naglazyme (enzyme replacement for MPS VI), and Kuvan (a cofactor therapy for phenylketonuria). The company’s products work by supplying missing or defective enzymes or cofactors in patients’ bodies, helping to treat the underlying metabolic problems. BioMarin differentiates itself through its specialization in rare diseases, building a pipeline of product candidates across stages of development and selling primarily to specialty pharmacies and hospitals. Its goal is to provide approved, accessible treatments for patients with limited options and to grow its portfolio to cover more rare genetic conditions.

Company size
1,001-5,000
Company stage
IPO
Headquarters
San Rafael, CA
Founded
1997

Recently Posted Jobs

Explore more opportunities at BioMarin

See more jobs